This document discusses retinoblastoma, a rare eye cancer that affects children. It is the most common intraocular malignancy in childhood. If untreated, children typically die within 2-4 years of symptoms starting. The document covers epidemiology, genetics, clinical presentation, diagnosis, and management options like chemotherapy, radiation therapy, cryotherapy, laser therapy, and enucleation. Early detection and a multidisciplinary approach can help save the child's life and possibly preserve vision. Prognosis depends on factors like tumor size and extent of spread.